Business Context and Reporting Period
Company: Coca-Cola Europacific Partners Plc (CCEP)
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: July 30, 2025, to August 5, 2025
Business Overview: CCEP is a leading consumer goods company operating in 31 countries, serving nearly 600 million consumers and over 4 million customers. The company is listed on Euronext Amsterdam, NASDAQ, London Stock Exchange, and Spanish Stock Exchanges, and is a constituent of the NASDAQ 100 and FTSE 100 indices.
Key Financial Metrics and Transactions
This filing reports on the execution of the Company's share buyback programme announced on February 14, 2025, with an aggregate authorization of up to EUR 1 billion. All repurchased shares are cancelled.
| Date of Purchase | US Trading Venues (Shares) | London Trading Venues (Shares) | Total Shares Purchased | Avg. Price (USD) | Avg. Price (GBP) |
|---|---|---|---|---|---|
| July 29, 2025 | 35,821 | 16,694 | 52,515 | $98.72 | £73.95 |
| July 30, 2025 | 35,481 | 14,292 | 49,773 | $99.67 | £74.67 |
| July 31, 2025 | 35,945 | 17,069 | 53,014 | $98.38 | £74.69 |
| August 1, 2025 | 31,501 | 0 | 31,501 | $97.29 | N/A |
| August 4, 2025 | 31,395 | 0 | 31,395 | $97.62 | N/A |
Financial Metrics: The filing does not provide revenue, profit, cash flow, margins, debt, or liquidity figures. It is strictly a disclosure of share repurchase activity.
Material Changes
The filing details a consistent execution of the share buyback programme across five trading days. Notable observations include:
- Trading Venue Shift: Purchases on London Trading Venues ceased after July 31, 2025, with subsequent transactions (August 1 and August 4) occurring exclusively on US Trading Venues.
- Price Range: The volume-weighted average price on US venues ranged from approximately $97.29 to $99.67 during this period.
Guidance, Outlook, and Risks
Buyback Programme Status: The Company continues to execute its programme to repurchase up to EUR 1 billion of ordinary shares. The filing does not provide updated financial guidance, outlook, or management commentary regarding operational performance.
Risks and Contingencies: No specific risks or contingencies are disclosed in this filing beyond standard regulatory disclaimers regarding the Market Abuse Regulation.
Investor Verification Checklist
- Programme Remaining Capacity: Verify the total amount repurchased to date against the EUR 1 billion authorization to determine remaining capacity.
- Share Count Impact: Confirm the reduction in total outstanding shares due to the cancellation of the 218,198 shares repurchased in this specific period.
- Market Conditions: Review the correlation between the buyback execution dates and broader market movements for CCEP stock on US and London exchanges.
- Full Transaction Details: Consult the referenced RNS PDF schedules for granular transaction data required under the Market Abuse Regulation.